Cargando…

Prognostic variables for temporal lobe injury after intensity modulated‐radiotherapy of nasopharyngeal carcinoma

To determine predictive factors for temporal lobe injury (TLI) in nasopharyngeal carcinoma patient (NPC) treated with intensity‐modulated radiation therapy (IMRT). A total of 695 NPC cases treated with IMRT were retrospectively analyzed. TLI was diagnosed on MRI images. Volume‐dose histograms for 87...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Mei, Huang, Yecai, Fan, Xigang, Xu, Peng, Lang, Jinyi, Wang, Dian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852358/ https://www.ncbi.nlm.nih.gov/pubmed/29473319 http://dx.doi.org/10.1002/cam4.1291

Ejemplares similares

Clinical Outcomes and Prognostic Factors of 695 Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiotherapy
por: Wang, Weidong, et al.
Publicado: (2014)

Dosimetric analysis of radiation-induced brainstem necrosis for nasopharyngeal carcinoma treated with IMRT
por: Fan, Xigang, et al.
Publicado: (2022)

Clinical Outcome and Prognostic Factors of Intensity-Modulated Radiotherapy for T4 Stage Nasopharyngeal Carcinoma
por: Luo, Yangkun, et al.
Publicado: (2016)

Tumor volume is an independent prognostic indicator of local control in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy
por: Feng, Mei, et al.
Publicado: (2013)

Radiation-Induced Temporal Lobe Injury for Nasopharyngeal Carcinoma: A Comparison of Intensity-Modulated Radiotherapy and Conventional Two-Dimensional Radiotherapy
por: Zhou, Guan-Qun, et al.
Publicado: (2013)

Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study
por: Huang, Juan, et al.
Publicado: (2019)

Half-Brain Delineation for Prediction of Radiation-Induced Temporal Lobe Injury in Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy
por: Du, Qing-Hua, et al.
Publicado: (2021)

The development and external validation of simplified T category classification for nasopharyngeal carcinoma to improve the prognostic value in the intensity‐modulated radiotherapy era
por: Tang, Ling‐Long, et al.
Publicado: (2019)

Prognostic value of pretreatment (18)F-FDG PET-CT for nasopharyngeal carcinoma patients
por: Huang, Yecai, et al.
Publicado: (2017)

LASSO-based NTCP model for radiation-induced temporal lobe injury developing after intensity-modulated radiotherapy of nasopharyngeal carcinoma
por: Kong, Cheng, et al.
Publicado: (2016)

Development and Validation of a Nomogram for Predicting Radiation-Induced Temporal Lobe Injury in Nasopharyngeal Carcinoma
por: Guan, Wenqiang, et al.
Publicado: (2020)

Comparison of radiological and clinical features of temporal lobe necrosis in nasopharyngeal carcinoma patients treated with 2D radiotherapy or intensity-modulated radiotherapy
por: Mao, Y-P, et al.
Publicado: (2014)

Radiation-induced temporal lobe injury after intensity modulated radiotherapy in nasopharyngeal carcinoma patients: a dose-volume-outcome analysis
por: Sun, Ying, et al.
Publicado: (2013)

Analysis of dosimetric factors associated with temporal lobe necrosis (TLN) in patients with nasopharyngeal carcinoma (NPC) after intensity modulated radiotherapy
por: Su, Sheng-Fa, et al.
Publicado: (2013)

Local regression and control of T1‐2 nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy
por: Xue, Fen, et al.
Publicado: (2018)

Added value of histogram analysis of ADC in predicting radiation-induced temporal lobe injury of patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapy
por: Bao, Dan, et al.
Publicado: (2022)

Temporal Lobe Necrosis Following Radiotherapy in Nasopharyngeal Carcinoma: New Insight Into the Management
por: Zhou, Xin, et al.
Publicado: (2021)

Effect of Kangfuxin Solution on Chemo/Radiotherapy-Induced Mucositis in Nasopharyngeal Carcinoma Patients: A Multicenter, Prospective Randomized Phase III Clinical Study
por: Luo, Yangkun, et al.
Publicado: (2016)

Combined prognostic value of pretreatment anemia and cervical node necrosis in patients with nasopharyngeal carcinoma receiving intensity‐modulated radiotherapy: A large‐scale retrospective study
por: Zhang, Lu‐Lu, et al.
Publicado: (2017)

Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy
por: Wu, Shixiu, et al.
Publicado: (2015)

Toripalimab plus intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma: an open-label single-arm, phase II trial
por: Hua, Yijun, et al.
Publicado: (2021)

Development and validation of a model for temporal lobe necrosis for nasopharyngeal carcinoma patients with intensity modulated radiation therapy
por: Wang, Jiazhou, et al.
Publicado: (2019)

Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
por: Tian, Y-M, et al.
Publicado: (2014)

Prognostic nomogram of xerostomia for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy
por: Pan, Xin-Bin, et al.
Publicado: (2020)

Prognostic value of radiation interruption in different periods for nasopharyngeal carcinoma patients in the intensity‐modulated radiation therapy era
por: Yang, Xing‐Li, et al.
Publicado: (2020)

Dynamic MRI follow-up of radiation encephalopathy in the temporal lobe following nasopharyngeal carcinoma radiotherapy
por: Zhou, Xiaofeng, et al.
Publicado: (2017)

Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy
por: Liao, Jun-Fang, et al.
Publicado: (2016)

Necessity of concurrent chemotherapy in N2‐3 nasopharyngeal carcinoma treated with neoadjuvant chemotherapy of ≥3 cycles followed by intensity‐modulated radiotherapy
por: Chang, Hui, et al.
Publicado: (2019)

DW-MRI-Guided Dose Escalation Improves Local Control of Locally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy
por: Huang, Yecai, et al.
Publicado: (2020)

Prognostic value of Ki-67 in nasopharyngeal carcinoma: a meta-analysis
por: Li, Yulin, et al.
Publicado: (2021)

Thyroid dose‐volume thresholds for the risk of radiation‐related hypothyroidism in nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy—A single‐institution study
por: Huang, Cheng‐Long, et al.
Publicado: (2019)

Prognostic values of hematological biomarkers in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy
por: Ye, Lulu, et al.
Publicado: (2018)

Apolipoprotein A-I Is a Prognosticator of Nasopharyngeal Carcinoma in the Era of Intensity-modulated Radiotherapy
por: Chang, Hui, et al.
Publicado: (2018)

Prognostic Value of Inflammatory Markers in Nasopharyngeal Carcinoma Patients in the Intensity-Modulated Radiotherapy Era
por: Li, Qian, et al.
Publicado: (2021)

Radiation induced temporal lobe necrosis in nasopharyngeal cancer patients after radical external beam radiotherapy
por: Wu, Vincent W. C., et al.
Publicado: (2020)

Development and prospective validation of a risk score model in guiding individualized concurrent chemoradiotherapy in stage II nasopharyngeal carcinoma in intensity‐modulated radiotherapy era
por: Yang, Shan‐Shan, et al.
Publicado: (2021)

Prognostic value of parotid lymph node metastasis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy
por: Zhang, Yuan, et al.
Publicado: (2015)

Analysis of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma
por: Wu, Shihai, et al.
Publicado: (2020)

Prognostic score models for survival of nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy and chemotherapy
por: Zeng, Lei, et al.
Publicado: (2015)

Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy
por: Mao, Yan-Ping, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_au4qis8cvu22dhfm2bchvhfgqa